Literature DB >> 721834

Synergistic regulation of phosphorylase a by glucose and caffeine.

P J Kasvinsky, S Shechosky, R J Fletterick.   

Abstract

Kinetic studies of both liver and muscle phosphorylase a demonstrate that caffeine and glucose inhibit the binding of glucose 1-phosphate to the enzyme in a synergistic competitive and nonexclusive manner. Inhibition studies for numerous other caffeine analogs show that the muscle enzyme has a relaxed specificity for this negative effector. The liver enzyme is more discriminating by preferential binding of methylated oxypurines. Physiological concentrations of AMP and ATP, which affect the enzymic activity at a separate site, prevent glucose from effectively inhibiting the enzyme. The addition of the second synergistic ligand improves the binding of glucose. These data suggest that glucose homeostasis as regulated by phosphorylase may be dependent on a second ligand and that the role of glucose in this physiological process may have been overestimated. A structural rationalization of this synergistic response is discussed with reference to the crystal structure of the muscle enzyme.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 721834

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  Effects of commonly used cryoprotectants on glycogen phosphorylase activity and structure.

Authors:  K E Tsitsanou; N G Oikonomakos; S E Zographos; V T Skamnaki; M Gregoriou; K A Watson; L N Johnson; G W Fleet
Journal:  Protein Sci       Date:  1999-04       Impact factor: 6.725

2.  Sensitivity of glycogen phosphorylase isoforms to indole site inhibitors is markedly dependent on the activation state of the enzyme.

Authors:  S Freeman; J B Bartlett; G Convey; I Hardern; J L Teague; S J G Loxham; J M Allen; S M Poucher; A D Charles
Journal:  Br J Pharmacol       Date:  2006-10-03       Impact factor: 8.739

3.  Discovery of a human liver glycogen phosphorylase inhibitor that lowers blood glucose in vivo.

Authors:  W H Martin; D J Hoover; S J Armento; I A Stock; R K McPherson; D E Danley; R W Stevenson; E J Barrett; J L Treadway
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-17       Impact factor: 11.205

4.  Phosphorylation-induced conformational changes in the phosphorylase ab hybrid as revealed by resolution of pyridoxal 5'-phosphate with imidazole citrate and cysteine.

Authors:  G Vereb; E Pallagi; P Gergely
Journal:  Mol Cell Biochem       Date:  1992-03-25       Impact factor: 3.396

5.  Allosteric inhibition of glycogen phosphorylase a by the potential antidiabetic drug 3-isopropyl 4-(2-chlorophenyl)-1,4-dihydro-1-ethyl-2-methyl-pyridine-3,5,6-tricarbo xylate.

Authors:  N G Oikonomakos; K E Tsitsanou; S E Zographos; V T Skamnaki; S Goldmann; H Bischoff
Journal:  Protein Sci       Date:  1999-10       Impact factor: 6.725

Review 6.  The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux.

Authors:  Varman T Samuel; Gerald I Shulman
Journal:  J Clin Invest       Date:  2016-01-04       Impact factor: 14.808

7.  Kinetic mechanism of the glycogen-phosphorylase-catalysed reaction in the direction of glycogen synthesis: co-operative interactions of AMP and glucose 1-phosphate during catalysis.

Authors:  E A Sergienko; D K Srivastava
Journal:  Biochem J       Date:  1997-11-15       Impact factor: 3.857

8.  The effect of glucose on the potency of two distinct glycogen phosphorylase inhibitors.

Authors:  Birgitte Andersen; Niels Westergaard
Journal:  Biochem J       Date:  2002-10-15       Impact factor: 3.857

9.  N-acetyl-beta-D-glucopyranosylamine: a potent T-state inhibitor of glycogen phosphorylase. A comparison with alpha-D-glucose.

Authors:  N G Oikonomakos; M Kontou; S E Zographos; K A Watson; L N Johnson; C J Bichard; G W Fleet; K R Acharya
Journal:  Protein Sci       Date:  1995-12       Impact factor: 6.725

10.  The binding of D-gluconohydroximo-1,5-lactone to glycogen phosphorylase. Kinetic, ultracentrifugation and crystallographic studies.

Authors:  A C Papageorgiou; N G Oikonomakos; D D Leonidas; B Bernet; D Beer; A Vasella
Journal:  Biochem J       Date:  1991-03-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.